BioCentury
ARTICLE | Product Development

Limits of detection for FDA-authorized COVID-19 diagnostics

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

April 2, 2020 12:53 AM UTC
Updated on Apr 4, 2020 at 1:27 AM UTC


Access this Article